Panagora Asset Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-51,966
| Closed | -$3.52M | – | 2686 |
|
|
2019
Q3 | $3.52M | Sell |
51,966
-2,256
| -4% | -$155K | 0.02% | 562 |
|
|
2019
Q2 | $3.15M | Sell |
54,222
-9,908
| -15% | -$587K | 0.01% | 647 |
|
|
2019
Q1 | $4.49M | Sell |
64,130
-206
| -0.3% | -$15.3K | 0.02% | 541 |
|
|
2018
Q4 | $4.14M | Sell |
64,336
-50,210
| -44% | -$3.52M | 0.02% | 517 |
|
|
2018
Q3 | $8.04M | Sell |
114,546
-96,388
| -46% | -$5.64M | 0.03% | 410 |
|
|
2018
Q2 | $10.6M | Buy |
210,934
+38,228
| +22% | +$1.52M | 0.04% | 339 |
|
|
2018
Q1 | $5.4M | Buy |
172,706
+1,628
| +1% | +$54K | 0.02% | 509 |
|
|
2017
Q4 | $5.85M | Sell |
171,078
-12,847
| -7% | -$410K | 0.02% | 503 |
|
|
2017
Q3 | $5.9M | Buy |
183,925
+20,338
| +12% | +$641K | 0.02% | 528 |
|
|
2017
Q2 | $5.33M | Buy |
163,587
+90,188
| +123% | +$2.86M | 0.02% | 562 |
|
|
2017
Q1 | $2.31M | Buy |
73,399
+3,477
| +5% | +$103K | 0.01% | 827 |
|
|
2016
Q4 | $2.06M | Sell |
69,922
-2,998
| -4% | -$91.4K | 0.01% | 892 |
|
|
2016
Q3 | $2.11M | Buy |
72,920
+59,833
| +457% | +$1.67M | 0.01% | 879 |
|
|
2016
Q2 | $339K | Sell |
13,087
-2,730
| -17% | -$72.5K | ﹤0.01% | 1487 |
|
|
2016
Q1 | $392K | Buy |
15,817
+1,042
| +7% | +$28.6K | ﹤0.01% | 1428 |
|
|
2015
Q4 | $520K | Buy |
14,775
+1,688
| +13% | +$45.2K | ﹤0.01% | 1305 |
|
|
2015
Q3 | $277K | Sell |
13,087
-3,641
| -22% | -$93.8K | ﹤0.01% | 1507 |
|
|
2015
Q2 | $465K | Buy |
16,728
+3,641
| +28% | +$103K | ﹤0.01% | 1359 |
|
|
2015
Q1 | $400K | Sell |
13,087
-2,031
| -13% | -$64.6K | ﹤0.01% | 1411 |
|
|
2014
Q4 | $483K | Hold |
15,118
| – | – | ﹤0.01% | 1298 |
|
|
2014
Q3 | $428K | Sell |
15,118
-3,743
| -20% | -$104K | ﹤0.01% | 1366 |
|
|
2014
Q2 | $517K | Sell |
18,861
-11,309
| -37% | -$301K | ﹤0.01% | 1362 |
|
|
2014
Q1 | $795K | Buy |
30,170
+6,205
| +26% | +$178K | ﹤0.01% | 1271 |
|
|
2013
Q4 | $701K | Sell |
23,965
-3,956
| -14% | -$126K | ﹤0.01% | 1289 |
|
|
2013
Q3 | $854K | Sell |
27,921
-872
| -3% | -$29.2K | ﹤0.01% | 1171 |
|
|
2013
Q2 | $913K | Buy |
+28,793
| New | +$946K | ﹤0.01% | 1096 |
|
Panagora Asset Management's GHDX Position: Q4 2019 in Review
Panagora Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 51,966 shares — an estimated $3.52M sold.
Panagora Asset Management first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $10.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Panagora Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Panagora Asset Management sold 51,966 Genomic Health, Inc. shares in Q4 2019, an estimated $3.52M.
- Panagora Asset Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Panagora Asset Management's Genomic Health, Inc. position peaked at $10.6M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Panagora Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.